{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:54:34Z","timestamp":1761515674138,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.4158\/ep10026.cr","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T21:30:11Z","timestamp":1272922211000},"page":"669-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Achievement of Fertility in an Infertile Man With Resistant Macroprolactinoma Using High-Dose Bromocriptine and a Combination of Human Chorionic Gonadotropin and an Aromatase Inhibitor"],"prefix":"10.1016","volume":"16","author":[{"given":"Zahra","family":"Heidari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Hosseinpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Shirazian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP10026.CR_bb0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"10.4158\/EP10026.CR_bb0015","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","article-title":"Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy","volume":"86","author":"Di Sarno","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10026.CR_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","article-title":"Pharmacologic resistance in prolactinoma patients","volume":"8","author":"Molitch","year":"2005","journal-title":"Pituitary"},{"key":"10.4158\/EP10026.CR_bb0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem.82.3.3822","article-title":"Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10026.CR_bb0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM198309223091205","article-title":"Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone","volume":"309","author":"Kleinberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.4158\/EP10026.CR_bb0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","article-title":"Dopamine agonists and pituitary tumor shrinkage","volume":"13","author":"Bevan","year":"1992","journal-title":"Endocr Rev"},{"key":"10.4158\/EP10026.CR_bb0040","first-page":"3053","article-title":"Primary medical therapy of microand macroprolactinomas in men","volume":"85","author":"Pinzone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10026.CR_bb0045","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1210\/jc.2002-020426","article-title":"The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma","volume":"87","author":"Gillam","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10026.CR_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jcem-64-2-391","article-title":"Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen","volume":"64","author":"Prior","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10026.CR_bb0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM197810192991602","article-title":"Prolactin-screening tumors and hypogonadism in 22 men","volume":"299","author":"Carter","year":"1978","journal-title":"N Engl J Med"},{"key":"10.4158\/EP10026.CR_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0015-0282(16)44359-1","article-title":"Male hyperprolactinemia: effects on fertility","volume":"32","author":"Segal","year":"1979","journal-title":"Fertil Steril"},{"key":"10.4158\/EP10026.CR_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11102-005-5084-3","article-title":"PRL secreting adenomas in male patients","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"10.4158\/EP10026.CR_bb0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0889-8529(05)70203-6","article-title":"Disorders of prolactin secretion","volume":"30","author":"Molitch","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP10026.CR_bb0075","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/jcem-69-3-500","article-title":"Resistance to bromocriptine in prolactinomas","volume":"69","author":"Pellegrini","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10026.CR_bb0080","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1210\/jc.2007-2758","article-title":"Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients","volume":"93","author":"Ono","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10026.CR_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"10.4158\/EP10026.CR_bb0090","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1073\/pnas.75.12.5946","article-title":"Estrogen control of prolactin synthesis in vitro","volume":"75","author":"Lieberman","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10026.CR_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/endo-70-2-272","article-title":"Estrogen stimulation of prolactin production by rat adenohypophysis in vitro","volume":"70","author":"Nicoll","year":"1962","journal-title":"Endocrinology"},{"key":"10.4158\/EP10026.CR_bb0100","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1126\/science.418505","article-title":"Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release","volume":"200","author":"Raymond","year":"1978","journal-title":"Science"},{"key":"10.4158\/EP10026.CR_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1022176631922","article-title":"Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats","volume":"5","author":"Carretero","year":"2002","journal-title":"Pituitary"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20408195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20408195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/TM7937H088000806.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:25Z","timestamp":1761515425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20408195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1530891X20408195"],"URL":"https:\/\/doi.org\/10.4158\/ep10026.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achievement of Fertility in an Infertile Man With Resistant Macroprolactinoma Using High-Dose Bromocriptine and a Combination of Human Chorionic Gonadotropin and an Aromatase Inhibitor","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP10026.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}